A Profile of Glucose-6-Phosphate Dehydrogenase Variants and Deficiency of Multicultural Families in Korea
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Vivax malaria incidence in Korea is now decreased and showing a low plateau. Nowadays, vivax malaria in Korea is expected to be successfully eliminated with anti-malaria chemotherapy, primaquine, and vector control. The glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with potential hemolytic anemia after primaquine administration. This inborn disorder has a pivotal polymorphism with genetic variants and is the most prevalent X-chromosome-linked disorder. The prevalence of G6PD deficiency was previously reported negligible in Korea. As the population of multicultural families pertaining marriage immigrants and their adolescents increases, it is necessary to check G6PD deficiency for them prior to primaquine treatment for vivax malaria. The prevalence of G6PD variants and G6PD deficiency in multicultural families was performed in 7 counties and 2 cities of Jeollanam-do (Province), Gyeonggi-do, and Gangwon-do. A total of 733 blood samples of multicultural family participants were subjected to test the phenotypic and genetic G6PD deficiency status using G6PD enzyme activity quantitation kit and PCR-based G6PD genotyping kit. The G6PD phenotypic deficiency was observed in 7.8% of male adolescent participants and 3.2% of materfamilias population. Based on the PCR-based genotyping, we observed total 35 participants carrying the mutated alleles. It is proposed that primaquine prescription should seriously be considered prior to malaria treatment.
Abstract
Vivax malaria incidence in Korea is now decreased and showing a low plateau. Nowadays, vivax malaria in Korea is expected to be successfully eliminated with anti-malaria chemotherapy, primaquine, and vector control. The glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with potential hemolytic anemia after primaquine administration. This inborn disorder has a pivotal polymorphism with genetic variants and is the most prevalent X-chromosome-linked disorder. The prevalence of G6PD deficiency was previously reported negligible in Korea. As the population of multicultural families pertaining marriage immigrants and their adolescents increases, it is necessary to check G6PD deficiency for them prior to primaquine treatment for vivax malaria. The prevalence of G6PD variants and G6PD deficiency in multicultural families was performed in 7 counties and 2 cities of Jeollanam-do (Province), Gyeonggi-do, and Gangwon-do. A total of 733 blood samples of multicultural family participants were subjected to test the phenotypic and genetic G6PD deficiency status using G6PD enzyme activity quantitation kit and PCR-based G6PD genotyping kit. The G6PD phenotypic deficiency was observed in 7.8% of male adolescent participants and 3.2% of materfamilias population. Based on the PCR-based genotyping, we observed total 35 participants carrying the mutated alleles. It is proposed that primaquine prescription should seriously be considered prior to malaria treatment.
참고문헌 (24)
- Chen EY, "Sequence of human glucose6-phosphate dehydrogenase cloned in plasmids and a yeast artificial chromosome", Genomics, 10, pp.792~800 (1991)[DOI]
- Cappellini MD, "Glucose-6-phosphate dehydrogenase deficiency", Lancet, 371, pp.64~74 (2008)[DOI]
- Luzzatto L, "Glucose-6-phhosphate dehydrogenase deficiency", Hematol Oncol Clin North Am, 30, pp.373~393 (2016)[DOI]
- Vulliamy T, "he molecular basis of glucose6-phosphate dehydrogenase deficiency", Trends Genet, 8, pp.138~143 (1992)[DOI]
- WHO Working Group, "Glucose-6-phosphate dehydrogenase deficiency", Bull World Health Organ, 67, pp.601~611 (1989)
- Motulsky AG, "Metabolic polymorphisms and the role of infectious diseases in human evolution", Hum Biol, 32, pp.28~62 (1960)
- Marla KJ, "Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility", PLoS One, 4, pp.e7246~ (2009)[DOI]
- Verlé P, "Glucose-6-phosphate dehydrogenase deficiency in northern Vietnam", Trop Med Int Health, 5, pp.203~206 (2000)[DOI]
- Saha N, "Distribution of glucose-6-phosphate dehydrogenase phenotypes in five East Asian population groups", Ann Acad Med Singap, 13, pp.494~497 (1984)
- Goo YK, "First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea", PLoS One, 9, pp.e97390~ (2014)[DOI]
- Lee W, "Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea", Malar J, 19, pp.317~ (2020)[DOI]
- Beutler E, "G6PD: Population genetics and clinical manifestations", Blood Rev, 10, pp.45~52 (1996)[DOI]
- 박영일, "Epidemiological Characteristics of Re-emerging Vivax Malaria in the Republic of Korea (1993-2017)", The Korean Journal of Parasitology, 56(6), pp.531~543 (2018), 대한기생충학ㆍ열대의학회
- Ashley EA, "Primaquine: the risks and the benefits", Malar J, 12, pp.1~ (2014)[DOI]
- "Guideline for the Treatment of Malaria"[URL]
- Judith Recht, "Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries", PLOS Neglected Tropical Diseases, 12(4), pp.e0006230~ (2018), Public Library of Science (PLoS)[DOI]
- 이재웅, "Genetic Profiles of Korean Patients With Glucose-6-Phosphate Dehydrogenase Deficiency", Annals of Laboratory Medicine, 37(2), pp.108~116 (2017), 대한진단검사의학회
- "Korean social trends 2019 (11-1240245-00014-10)" (2019)[URL]
- Jalil N, "Evaluation of glucose-6-phosphatase dehydrogenase stability in stored blood samples", EXCLI J, 15, pp.155~162 (2016)[DOI]
- "WHO Guidelines for Malaria" (2021)[URL]
- "Status of Foreign Residents"[URL]
- "The Adolescents People" (2019)[URL]
- Kim MK, "Glucose-6-phosphate dehydrogenase deficiency–report of 4 cases", J Korean Med Sci, 7, pp.71~75 (1992)[DOI]
- Jang MA, "A novel de novo mutation in the G6PD gene in a Korean boy with glucose6-phosphate dehydrogenase deficiency: case report", Ann Clin Lab Sci, pp.446~448 (2015)